REMI

Mumbai, India Founded: 1960 • Age: 66 yrs Listed
Blood bank and laboratory equipment are manufactured by REMI.

About REMI

REMI is a publicly listed company based in Mumbai (India) founded in 1960. It operates as a blood bank and laboratory equipment are manufactured by REMI. The company has 182 employees. Its website remilabworld.com draws about 21 thousand monthly visits. Its Indian entity Remi Sales And Engineering Limited reported revenue of β‚Ή180 Cr. REMI offers products and services including Laboratory Equipment and Healthcare Equipment.

Company details

REMI was established in 1960 and is headquartered in Mumbai, India. Equipment for blood banks and laboratories is produced by the company within the medical and scientific sector. Operations focus on design, fabrication, and distribution of specialized instruments. The domain remilabworld.com supports online presence and client interactions. Activities are centered in India, serving domestic and potential international markets with standard laboratory tools.

Key Metrics
  • Annual Revenue
    ₹180 Cr

    FY 2025 · +8% YoY

  • Net Profit
    ₹9.35 Cr

    FY 2025 · 5% margin

  • EBITDA
    ₹12.52 Cr

    FY 2025 · 7% margin

  • Employee Count
    182

Products & Services of REMI

REMI offers a comprehensive portfolio of products and services, including Laboratory Equipment and Healthcare Equipment.

Laboratory Equipment
Scientific Instruments

Laboratory instruments such as stirrers and centrifuges are manufactured and supplied to serve scientific and research applications

Healthcare Equipment
Medical Devices

Healthcare products like blood bank refrigerators and freezers are produced and exported to meet medical and storage requirements

Apps and channels of REMI

its YouTube channel Remi Lab World has 287 subscribers and 30 videos.

Remi Lab World
YouTube 287 subscribers 30 videos Science & Technology
Open channel

Videos from REMI

The most watched videos on REMI's YouTube channel, Remi Lab World (287 subscribers). Click a video to play it here.

Unboxing and Installation of R-8C PLUS Centrifuge Models Included:R-8C Plus,R-8CBL,R-12C Plus
3.2K views
REMI - Importance of PRP Therapy
2.8K views
Unboxing and Installation of R-8C Centrifuge Models Included:R-8C,R-4C,RM-12C
2.2K views
REMI LAB WORLD - AN INTRODUCTION
2K views

More on Remi Lab World.

Board of directors of Remi Sales And Engineering Limited (REMI)

Remi Sales And Engineering Limited is the primary company behind REMI. The board of Remi Sales And Engineering Limited currently have 5 directors; the longest-serving is Vinod Chiranjilal Jalan, appointed in 2021. 6 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vinod Chiranjilal Jalan
DIN 00087424
Director11 Aug 20215 yrs 2 moRemi Sales And Engineering Limited
Ritvik Saraf
DIN 01638851
Whole-time director01 Dec 20214 yrs 10 moRemi Sales And Engineering Limited
Bhagirath Singh
DIN 00155407
Director01 Jul 20224 yrs 3 moRemi Sales And Engineering Limited
Anita Vinod Bhartiya
DIN 01579145
Director30 Sep 20242 yrsRemi Sales And Engineering Limited
Vishwambhar Chiranjilal Saraf
DIN 00161381
Director01 Oct 20242 yrsRemi Sales And Engineering Limited

Financials of REMI

Figures of Remi Sales And Engineering Limited, the primary company behind REMI, for FY 2025. Revenue was ₹180 Cr (+8% year on year). Net profit was ₹9.35 Cr (5% margin). EBITDA was ₹12.52 Cr (7% margin). Revenue has grown at a compounded annual rate of +6% over three years and +5% over five years.

  • ₹180 CrRevenue · FY 2025 · +8% YoY
  • ₹9.35 CrNet profit · 5% margin
  • ₹12.52 CrEBITDA · 7% margin
  • ₹57 LakhPaid-up capital
  • 182Employees (provident fund records)
  • +6%Revenue CAGR, 3 years
  • +5%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Remi Sales And Engineering Limited are on its company page.

Premium access

Detailed financial statements for REMI

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of REMI

The website of REMI (remilabworld.com) receives about 21.4K visits a month.

  • Monthly visits
    21.4K

    ▲ 38.5% vs previous month

Similar websites

Websites whose visitors overlap most with REMI. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
lennox.ie
100%
–#2,742,035View details
shop.nanografi.com
shop.nanografi.com
96%
–#1,038,979–
remigroup.com
70%
1.9K#7,973,445View details
bionicsscientific.com
67%
–#2,897,486View details
tarsons.com
65%
41.6K#738,098View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 12 similar websites and full traffic analytics for REMI

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 12 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

10 companies that operate in the same segment as REMI (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B–1,111
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.34 BUSD 301.49 M1,372
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Remi

Remi Securities appoints Company Secretary
Business Standard β€’ 7 years ago
Remi Edelstahl Tubulars gets revision in credit ratings
Business Standard β€’ 8 years ago
Premium access

Complete news archive for REMI

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about REMI

REMI was founded in 1960.

REMI is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

REMI has 182 employees.

The primary company behind REMI, Remi Sales And Engineering Limited, reported revenue of β‚Ή180 Cr for FY 2025, up 8% year on year.

REMI was established in 1960 and is headquartered in Mumbai, India. Equipment for blood banks and laboratories is produced by the company within the medical and scientific sector. Operations focus on design, fabrication, and distribution of specialized instruments. The domain remilabworld.com supports online presence and client interactions. Activities are centered in India, serving domestic and potential international markets with standard laboratory tools.

REMI offers Laboratory Equipment and Healthcare Equipment.

REMI operates through Remi Sales And Engineering Limited.

The legal entities of REMI currently have 5 directors, including Anita Vinod Bhartiya, Vishwambhar Chiranjilal Saraf, Vinod Chiranjilal Jalan and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available